Published in Neurol Res on April 28, 2015
Diabetes and Risk of Surgical Site Infection: A Systematic Review and Meta-analysis. Infect Control Hosp Epidemiol (2015) 0.87
Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival. Biomaterials (2016) 0.81
Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review. World J Surg Oncol (2016) 0.75
Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy. Patient Prefer Adherence (2016) 0.75
Surgical Site Infection after Malignant Brain Tumor Resection: A Multicenter Study for Induction of a Basic Care Bundle. Neurol Med Chir (Tokyo) (2017) 0.75
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
Universal definition of myocardial infarction. Circulation (2007) 11.69
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A (2013) 6.88
PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron (2006) 5.34
Altered telomeres in tumors with ATRX and DAXX mutations. Science (2011) 4.60
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg (2003) 3.91
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget (2012) 3.88
Pediatric intracranial aneurysms: durability of treatment following microsurgical and endovascular management. J Neurosurg (2006) 3.73
Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells (2007) 3.47
The minipterional craniotomy for anterior circulation aneurysms: initial experience with 72 patients. Neurosurgery (2014) 3.26
Patterns of care for adults with newly diagnosed malignant glioma. JAMA (2005) 3.08
Achieving the National Quality Forum's "Never Events": prevention of wrong site, wrong procedure, and wrong patient operations. Ann Surg (2007) 3.04
Autoimmune hypophysitis. Endocr Rev (2005) 2.86
Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg (2009) 2.70
Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater (2003) 2.65
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci Transl Med (2013) 2.58
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov (2012) 2.39
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int J Radiat Oncol Biol Phys (2013) 2.28
Prospective evaluation of pain and analgesic use following major elective intracranial surgery. J Neurosurg (2007) 2.26
Seizure control for patients undergoing meningioma surgery. World Neurosurg (2012) 2.19
Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg (2010) 2.11
Preoperative charlson comorbidity score predicts postoperative outcomes among older intracranial meningioma patients. World Neurosurg (2011) 2.09
The transconjunctival transorbital approach: a keyhole approach to the midline anterior skull base. World Neurosurg (2012) 2.09
Craniofacial resection of midline anterior skull base malignancies: a reassessment of outcomes in the modern era. World Neurosurg (2011) 2.08
Integrative model of genomic factors for determining binding site selection by estrogen receptor-α. Mol Syst Biol (2010) 2.04
"Any possible restoration of function could not occur": Harvey Cushing and the early description of brain death. World Neurosurg (2011) 2.03
Intraoperative changes in transcranial motor evoked potentials and somatosensory evoked potentials predicting outcome in children with intramedullary spinal cord tumors. J Neurosurg Pediatr (2014) 2.03
Diagnosis and management of sacral Tarlov cysts. Case report and review of the literature. Neurosurg Focus (2003) 2.01
En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine (2005) 1.99
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg (2009) 1.91
Central nervous system cancers. J Natl Compr Canc Netw (2013) 1.82
Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery (2009) 1.79
Intraoperative ultrasonography as a guide to patient selection for duraplasty after suboccipital decompression in children with Chiari malformation Type I. J Neurosurg Pediatr (2008) 1.75
Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery (2008) 1.72
Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg (2012) 1.72
Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents. Cancer Biol Ther (2004) 1.71
Disparities in access to neuro-oncologic care in the United States. Arch Surg (2010) 1.67
Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells. Clin Cancer Res (2012) 1.67
Efficacy of intravenous patient-controlled analgesia after supratentorial intracranial surgery: a prospective randomized controlled trial. Clinical article. J Neurosurg (2009) 1.64
A bacterial protein enhances the release and efficacy of liposomal cancer drugs. Science (2006) 1.64
Combined microsurgical and endovascular management of complex intracranial aneurysms. Neurosurgery (2003) 1.64
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. J Clin Oncol (2005) 1.63
Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A (2004) 1.63
Targeted therapy for brain tumours. Nat Rev Drug Discov (2004) 1.63
Establishment and characterization of a primary human chordoma xenograft model. J Neurosurg (2012) 1.60
Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer (2008) 1.56
Introducer catheter for fiberoptic intubation does exist. Anesth Analg (2006) 1.56
The extended retrosigmoid approach for neoplastic lesions in the posterior fossa: technique modification. Neurosurg Rev (2010) 1.54
Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats. J Neurosurg (2002) 1.54
Predictors of length of stay in patients having elective colorectal surgery within an enhanced recovery protocol. Int J Surg (2010) 1.52
Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer. Cancer Cell (2010) 1.51
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol (2013) 1.51
Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer. Clin Cancer Res (2006) 1.50
Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. J Neuropathol Exp Neurol (2006) 1.50
A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg (2010) 1.47
Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosurgery (2004) 1.47
Postoperative mortality after surgery for brain tumors by patient insurance status in the United States. Arch Surg (2012) 1.47
Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg (2003) 1.47